Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth

PURPOSE: Glioblastoma (GBM) is classified as one of the most aggressive and lethal brain tumor. Great strides have been made in understanding the genomic and molecular underpinnings of GBM, which translated into development of new therapeutic approaches to combat such deadly disease. However, there...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jaehyun, Shin, Yong Jae, Lee, Kyoungmin, Cho, Hee Jin, Sa, Jason K., Lee, Sang-Yun, Kim, Seok-Hyung, Lee, Jeongwu, Yoon, Yeup, Nam, Do-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056981/
https://www.ncbi.nlm.nih.gov/pubmed/29129044
http://dx.doi.org/10.4143/crt.2017.315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056981/
https://www.ncbi.nlm.nih.gov/pubmed/29129044
http://dx.doi.org/10.4143/crt.2017.315

Ejemplares similares